GYRE icon

Gyre Therapeutics
GYRE

Overview Fund Activity

35 hedge funds and large institutions have $39.7M invested in Gyre Therapeutics in 2017 Q4 according to their latest regulatory filings, with 18 funds opening new positions, 6 increasing their positions, 4 reducing their positions, and 2 closing their positions.

Holders
35
Holders Change
+16
Holders Change %
+84.21%
% of All Funds
0.79%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.02%
New
18
Increased
6
Reduced
4
Closed
2
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

1
ACP
1
Acuta Capital Partners
California
$6.14M
2
ACA
2
Avoro Capital Advisors
New York
$5.46M
3
NC
3
Nexthera Capital
New York
$4.24M
4
VMI
4
VHCP Management II
New York
$3.22M
5
JGC
5
J. Goldman & Co
New York
$1.7M

Top Sellers

1
SCM
1
Sio Capital Management
New York
$2.76M
2
NMC
2
NEA Management Company
Maryland
$0
3
FPF
3
FNY Partners Fund
New York
$13K
4
Deutsche Bank
4
Deutsche Bank
Germany
$2K
5
FMA
5
FNY Managed Accounts
New York
$0
Name Holding Trade Value Shares
Change 		Shares
Change %
Barclays
26
Barclays
United Kingdom
$5K +$4.55K +40 +1,000%
Deutsche Bank
27
Deutsche Bank
Germany
$2K -$2.7K -27 -57%
TDC
28
Thompson Davis & Co
Virginia
$2K +$2K +17 New
IP
29
Intellectus Partners
California
$1K – – –
PAM
30
Panagora Asset Management
Massachusetts
$1K – – –
NMC
31
NEA Management Company
Maryland
– -$220K -5,799 Closed
FMA
32
FNY Managed Accounts
New York
– -$2K -53 Closed
1
2